Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Manganese | 16 | 2025 | 92 | 8.970 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 8 | 2021 | 33 | 4.310 |
Why?
|
| Repressor Proteins | 6 | 2025 | 273 | 4.060 |
Why?
|
| Astrocytes | 10 | 2021 | 244 | 3.540 |
Why?
|
| Manganese Poisoning | 5 | 2025 | 17 | 3.040 |
Why?
|
| Up-Regulation | 6 | 2025 | 536 | 2.710 |
Why?
|
| Dopamine | 7 | 2025 | 275 | 2.690 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 5 | 2020 | 14 | 2.380 |
Why?
|
| Tamoxifen | 3 | 2025 | 69 | 2.300 |
Why?
|
| Neuroprotective Agents | 4 | 2025 | 269 | 2.080 |
Why?
|
| YY1 Transcription Factor | 3 | 2021 | 14 | 2.080 |
Why?
|
| Brain | 5 | 2025 | 1472 | 1.520 |
Why?
|
| Estradiol | 3 | 2025 | 268 | 1.410 |
Why?
|
| Valproic Acid | 2 | 2018 | 21 | 1.080 |
Why?
|
| Tyrosine 3-Monooxygenase | 4 | 2025 | 92 | 1.060 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 1070 | 1.050 |
Why?
|
| Estrogen Receptor alpha | 2 | 2025 | 121 | 0.980 |
Why?
|
| Mice | 13 | 2025 | 6644 | 0.970 |
Why?
|
| Nervous System Diseases | 2 | 2019 | 77 | 0.970 |
Why?
|
| Animals | 23 | 2025 | 16992 | 0.950 |
Why?
|
| Microglia | 3 | 2024 | 208 | 0.950 |
Why?
|
| Behavior, Animal | 2 | 2025 | 373 | 0.920 |
Why?
|
| Substantia Nigra | 3 | 2024 | 52 | 0.920 |
Why?
|
| Serotonin | 2 | 2025 | 123 | 0.910 |
Why?
|
| Cell Line | 7 | 2025 | 1410 | 0.890 |
Why?
|
| beta Catenin | 1 | 2025 | 78 | 0.870 |
Why?
|
| Synaptic Transmission | 1 | 2025 | 149 | 0.840 |
Why?
|
| Sp1 Transcription Factor | 1 | 2024 | 46 | 0.840 |
Why?
|
| Cell Differentiation | 1 | 2025 | 638 | 0.720 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2017 | 38 | 0.720 |
Why?
|
| I-kappa B Kinase | 1 | 2021 | 51 | 0.670 |
Why?
|
| Lysophosphatidylcholines | 3 | 2005 | 22 | 0.670 |
Why?
|
| Mice, Knockout | 4 | 2025 | 1035 | 0.660 |
Why?
|
| Motor Activity | 3 | 2017 | 437 | 0.660 |
Why?
|
| Amino Acid Transport System X-AG | 2 | 2017 | 8 | 0.650 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2018 | 185 | 0.630 |
Why?
|
| Parkinson Disease | 2 | 2019 | 210 | 0.630 |
Why?
|
| alpha-Synuclein | 1 | 2018 | 61 | 0.560 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 532 | 0.560 |
Why?
|
| Neurons | 1 | 2025 | 1263 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 1869 | 0.530 |
Why?
|
| Caprylates | 1 | 2017 | 14 | 0.530 |
Why?
|
| Butyric Acid | 1 | 2017 | 19 | 0.530 |
Why?
|
| Oxidative Stress | 4 | 2024 | 1003 | 0.500 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2024 | 384 | 0.480 |
Why?
|
| Promoter Regions, Genetic | 3 | 2021 | 526 | 0.390 |
Why?
|
| Male | 10 | 2025 | 23409 | 0.330 |
Why?
|
| S-Adenosylmethionine | 3 | 2005 | 41 | 0.320 |
Why?
|
| Humans | 11 | 2025 | 43102 | 0.300 |
Why?
|
| Glutamic Acid | 2 | 2021 | 131 | 0.290 |
Why?
|
| Phosphatidylethanolamine N-Methyltransferase | 2 | 2005 | 6 | 0.290 |
Why?
|
| Locomotion | 2 | 2020 | 105 | 0.280 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2025 | 59 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2020 | 152 | 0.280 |
Why?
|
| Signal Transduction | 1 | 2017 | 2157 | 0.280 |
Why?
|
| Phospholipids | 2 | 2005 | 70 | 0.270 |
Why?
|
| Dopamine Antagonists | 2 | 2004 | 48 | 0.270 |
Why?
|
| Apoptosis | 3 | 2024 | 1568 | 0.250 |
Why?
|
| Cells, Cultured | 2 | 2021 | 1621 | 0.240 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2025 | 5 | 0.230 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2025 | 11 | 0.230 |
Why?
|
| MPTP Poisoning | 1 | 2005 | 12 | 0.230 |
Why?
|
| Transcription, Genetic | 2 | 2021 | 592 | 0.230 |
Why?
|
| Homocysteine | 1 | 2005 | 21 | 0.230 |
Why?
|
| Tyrosine | 1 | 2005 | 120 | 0.220 |
Why?
|
| Receptors, Dopamine | 1 | 2004 | 30 | 0.210 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 100 | 0.200 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 224 | 0.190 |
Why?
|
| Nerve Degeneration | 2 | 2017 | 111 | 0.180 |
Why?
|
| Autophagy | 1 | 2023 | 140 | 0.180 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2021 | 49 | 0.180 |
Why?
|
| Serine | 1 | 2021 | 79 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 386 | 0.170 |
Why?
|
| Manganese Compounds | 1 | 2020 | 15 | 0.170 |
Why?
|
| Methylation | 3 | 2005 | 119 | 0.160 |
Why?
|
| Mitochondria | 1 | 2024 | 523 | 0.160 |
Why?
|
| Protein Binding | 2 | 2020 | 1082 | 0.160 |
Why?
|
| Chlorides | 1 | 2020 | 59 | 0.160 |
Why?
|
| Brain Chemistry | 3 | 2005 | 141 | 0.160 |
Why?
|
| CREB-Binding Protein | 1 | 2020 | 13 | 0.160 |
Why?
|
| Rats | 5 | 2005 | 3735 | 0.160 |
Why?
|
| Histone Deacetylases | 1 | 2020 | 61 | 0.160 |
Why?
|
| Heme Oxygenase-1 | 1 | 2020 | 52 | 0.160 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 75 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2005 | 1766 | 0.150 |
Why?
|
| Neurotoxins | 1 | 2019 | 57 | 0.150 |
Why?
|
| Transcriptional Activation | 1 | 2020 | 173 | 0.150 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 1180 | 0.150 |
Why?
|
| Lewy Bodies | 1 | 2018 | 30 | 0.150 |
Why?
|
| Phosphorylation | 1 | 2021 | 986 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2020 | 92 | 0.140 |
Why?
|
| Down-Regulation | 1 | 2020 | 456 | 0.140 |
Why?
|
| Mutation | 1 | 2023 | 1177 | 0.140 |
Why?
|
| Anticonvulsants | 1 | 2018 | 40 | 0.140 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2017 | 18 | 0.140 |
Why?
|
| Base Sequence | 1 | 2020 | 983 | 0.140 |
Why?
|
| Malondialdehyde | 1 | 2017 | 42 | 0.140 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2017 | 76 | 0.130 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 14 | 0.130 |
Why?
|
| Ovariectomy | 1 | 2017 | 127 | 0.130 |
Why?
|
| Catalase | 1 | 2017 | 110 | 0.130 |
Why?
|
| Cerebellum | 1 | 2017 | 79 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 98 | 0.130 |
Why?
|
| Glutathione | 1 | 2017 | 171 | 0.130 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 665 | 0.120 |
Why?
|
| RNA, Messenger | 1 | 2020 | 1271 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 299 | 0.110 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 306 | 0.110 |
Why?
|
| Gene Expression | 1 | 2018 | 701 | 0.110 |
Why?
|
| Injections, Intraventricular | 2 | 2005 | 59 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2017 | 358 | 0.110 |
Why?
|
| Cell Survival | 1 | 2017 | 945 | 0.100 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 132 | 0.100 |
Why?
|
| Kinetics | 2 | 2005 | 695 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2005 | 465 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 1001 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 291 | 0.090 |
Why?
|
| Female | 2 | 2020 | 24698 | 0.070 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2005 | 11 | 0.060 |
Why?
|
| Phosphatidylethanolamines | 1 | 2005 | 17 | 0.060 |
Why?
|
| Catheterization | 1 | 2005 | 22 | 0.060 |
Why?
|
| Phosphatidylcholines | 1 | 2005 | 35 | 0.060 |
Why?
|
| Neostriatum | 1 | 2005 | 28 | 0.060 |
Why?
|
| PC12 Cells | 1 | 2005 | 93 | 0.060 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2005 | 28 | 0.060 |
Why?
|
| Quinacrine | 1 | 2005 | 5 | 0.060 |
Why?
|
| Hypokinesia | 1 | 2005 | 4 | 0.060 |
Why?
|
| Adenosine | 1 | 2005 | 62 | 0.060 |
Why?
|
| Chromatography, Thin Layer | 1 | 2005 | 39 | 0.060 |
Why?
|
| Gliosis | 1 | 2004 | 25 | 0.060 |
Why?
|
| Ibuprofen | 1 | 2004 | 34 | 0.060 |
Why?
|
| Apigenin | 1 | 2004 | 14 | 0.060 |
Why?
|
| Pyridinium Compounds | 1 | 2005 | 29 | 0.060 |
Why?
|
| Mazindol | 1 | 2004 | 4 | 0.050 |
Why?
|
| Tritium | 1 | 2004 | 46 | 0.050 |
Why?
|
| Radioligand Assay | 1 | 2004 | 65 | 0.050 |
Why?
|
| Methyltransferases | 1 | 2005 | 68 | 0.050 |
Why?
|
| Dizocilpine Maleate | 1 | 2004 | 43 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2004 | 109 | 0.050 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2004 | 46 | 0.050 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2004 | 92 | 0.050 |
Why?
|
| Benzazepines | 1 | 2004 | 33 | 0.050 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2004 | 83 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2004 | 240 | 0.050 |
Why?
|
| Benzamides | 1 | 2004 | 81 | 0.050 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2004 | 83 | 0.050 |
Why?
|
| Corpus Striatum | 1 | 2004 | 121 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 934 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 187 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 575 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2004 | 403 | 0.050 |
Why?
|
| Liver | 1 | 2005 | 511 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1124 | 0.040 |
Why?
|
| Mammals | 1 | 2019 | 112 | 0.040 |
Why?
|
| Annexin A5 | 1 | 2004 | 27 | 0.010 |
Why?
|
| Propidium | 1 | 2004 | 20 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2004 | 25 | 0.010 |
Why?
|
| G2 Phase | 1 | 2004 | 28 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 138 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 146 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2004 | 346 | 0.010 |
Why?
|
| DNA Damage | 1 | 2004 | 356 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2004 | 1455 | 0.010 |
Why?
|